Direct oral anticoagulants (DOACs) are used to prevent ischemic stroke in patients with atrial fibrillation (AF), but a significant risk of bleeds limit their use. Some patients refuse or are unable to adhere to this treatment. As 90% of AF-related thrombi originate in the left atrial appendage, its percutaneous or surgical closure (LAAC) emerged as an alternative.1 Though percutaneous LAAC is technically feasible, its exact place compared to DOAC remains unsettled.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Rod Passman
Building Out the Next Generation of Electrophysiologists: Interview With Rod Passman, MD, MSCE
You participated in the “Building Out the Next Generation of EPs” roundtable. What were the key themes or takeaways from the discussion? Were there any points of consensus—or debate—that stood out to you? At the Western AFib meeting, I was happy to participate in this roundtable talking about building out the next generation of electrophysiologists. It was a really robust discussion.
Promises and Perils of Consumer Mobile Technologies in Cardiovascular Care: JACC Scientific Statement
References 1. "2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in arrhythmia management: digital medical tools for heart rhythm professionals: from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society". J Arrhythm . 2021;37:271-319. 2. "Direct-to-consumer digital health". Lancet Digit Health . 2020;2:e163-e165. 3.
VIDEO: Wearable devices will need to be comfortable, fashionable
Source/Disclosures Source: Healio Interviews Disclosures: Passman reports receiving research support from the American Heart Association, Apple and the NIH and consulting for Abbott, Boston Scientific, Johnson & Johnson and Medtronic. Source/Disclosures Source: Healio Interviews Disclosures: Passman reports receiving research support from the American Heart Association, Apple and the NIH and consulting for Abbott, Boston Scientific, Johnson & Johnson and Medtronic.
Catheter Ablation for Persistent Atrial Fibrillation
[Skip to Navigation] January 10, 2023 JAMA. 2023;329(2):125-126. doi:10.1001/jama.2022.23953 Full Text Compared with treatments for other cardiac arrhythmias, the treatment of atrial fibrillation (AF) has changed dramatically in the last 25 years. The landmark work of Haïssaguerre et al1 established the pulmonary veins as the initiation site of AF in the majority of cases and launched the era of ablative therapies for this most common of arrhythmias.
Posterior wall isolation does not improve outcomes in ablation for persistent AF
Source/Disclosures Disclosures: Kistler reports receiving speaker fees from Abbott and serving on an advisory board for Biosense Webster. Please see the study for all other authors’ relevant financial disclosures. Passman reports receiving personal fees for serving on steering committees for Abbott and Medtronic, receiving grants from Abbott, the American Heart Association and the NHLBI and receiving royalties from UpToDate. We were unable to process your request. Please try again later.
Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke
Original Investigation September 29, 2021 JAMA Cardiol. Published online September 29, 2021. doi:10.1001/jamacardio.2021.3702 Key Points Question What is the temporal association between episodes of atrial fibrillation (AF) and ischemic stroke in patients with cardiac implantable electronic devices (CIEDs)? Findings In this case-crossover study including 891 patients with CIEDs and ischemic stroke, multihour AF episodes raised the odds of stroke 3.7-fold for up to 30 days.
Continuous AF monitoring does not reduce risk for stroke, systemic embolism: LOOP
August 29, 2021 3 min read Save Perspective from Source/Disclosures Published by: Source: Svendsen JH, et al. Hot Line: LOOP. Presented at: European Society of Cardiology Congress; Aug. 27-30, 2021 (virtual meeting). Disclosures: Svendsen reports serving on an advisory board for Medtronic and receiving speaking fees and research grants from Medtronic. Please see the study for all other authors’ relevant financial disclosures.
“Pill-in-Pocket” Anticoagulation for Atrial Fibrillation: Fiction, Fact, or Foolish?
Decision-making about anticoagulation is among the most challenging aspects of atrial fibrillation (AF) management from the perspectives of both patients and physicians. On one hand, AF-related stroke, the most feared sequela of the arrhythmia, is more likely to be fatal or severely debilitating than strokes from other causes and can often be prevented with oral anticoagulants.
For Patients: Atrial Fibrillation
Sign in to your personal account Institutional sign in: OpenAthens | Shibboleth Purchase access Buy this article and get unlimited access and a printable PDF ($30.00) - Sign in or create a free account Sign in to download free article PDFs Sign in to your personal account Institutional sign in: OpenAthens | Shibboleth Get free access to newly published articles Create a personal account or sign in to: Register for email alerts with links to free full-text articles Access PDFs of free...
Cardiovascular Risk Factors in Young Adolescents
close Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel In This Article Abstract and Introduction Abstract Objectives: Lifestyle behaviors relevant to cardiovascular health are learned during childhood and continued into adulthood. Children and adolescents who participate in unhealthy behaviors have a higher lifetime risk of cardiovascular disease in adulthood.
AF Symposium 2021 Summary: Pill-in-the-Pocket Anticoagulation for AF
Video AF Symposium 2021 Summary: Pill-in-the-Pocket Anticoagulation for AF Published: 16 Feb 2021 Views: 53 Likes: 0 Dr Rod Passman (Northwestern Memorial Hospital, Chicago, IL, US) talks about “pill-in-pocket” anticoagulation for atrial fibrillation. In this short summary, he compares the results of the REACT.COM and TACTIF-AF pilot studies and he discusses the REACT-AF study.
USPSTF: Evidence insufficient on benefits, risks of ECG to diagnose AF
“The USPSTF found inadequate evidence to determine whether screening with ECG and subsequent treatment in asymptomatic adults is more effective than usual care,” the USPSTF wrote. “At the same time, the harms of diagnostic follow-up and treatment prompted by abnormal ECG results are well-established.
Line of pacemakers with automatic MRI detection launched in US
Biotronik announced that a line of pacemakers with functionality to detect MRI fields is now available in the United States. The pacemaker (Edora SR-T, Biotronik) can be used on a variety of patient anatomies without affecting battery life, and can last within the patient for more than 13 years, according to a press release from the company. The device is the smallest of its kind with automatic MRI detection (MRI AutoDetect, Biotronik), according to the release.
Circulation Research
Background: Cryptogenic stroke accounts for 30% to 40% of ischemic stroke. It is essential to determine the possible culprit because this will improve secondary stroke prevention strategies. Methods: We performed a narrative nonsystematic review of the literature that included randomized trials, exploratory comparative studies, and case series on cryptogenic stroke.
Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate
Rationale: Fibrosis is an important structural contributor to formation of atrial fibrillation (AF) substrate in heart failure. Transforming growth factor-β (TGF-β) signaling is thought to be intricately involved in creation of atrial fibrosis.
New Appraisal of Atrial Fibrillation Burden and Stroke Prevention
Atrial fibrillation (AF) quintuples the risk of stroke, and patients with stroke and AF are the most likely to be left dead or permanently disabled.1–4 More than 5 million people in the United States and >8 million people in the European Union were estimated to have AF in 2010.5–7 The lifetime risk of AF is high, with a quarter of 40-year-old patients expected to develop AF during the course of their lifetime.8 Because of aging populations, the prevalence of AF in the United Sates is expected...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Rod
Contact Rod, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack